Chemotherapy regimens for intermediate stage rectal cancer include 5-fluorouracil, calcium folinic acid, oxaliplatin and 5-fluorouracil, calcium folinic acid, irinotecan and so on.
Intermediate stage rectal cancer (including patients with stage II and above) has indication for chemotherapy, and most patients need postoperative adjuvant chemotherapy or preoperative neoadjuvant chemotherapy.
Currently, more chemotherapy regimens include platinum combined with 5-fluorouracil chemotherapy and irinotecan combined with 5-fluorouracil chemotherapy. The most used platinum is oxaliplatin, and the options include SOX (oxaliplatin combined with Tegio), etc. Each option has its own adverse effects and indications.
The chemotherapy program for mid-stage rectal cancer needs to be selected according to the patient’s condition status and other choices after evaluation by professional doctors, and it is recommended to go to the hospital for clear diagnosis and treatment. Early detection and early treatment are favorable to the prognosis of the disease.